IL1B and adult-onset Still disease: In experimental studies on MAS in oncology, sJIA and AOSD, it has been observed that blocking the IL-1 receptor (IL-1Ra) has a beneficial effect; however, stopping IL-1β is beneficial for sJIA, but not for MAS that may occur in sJIA.